Faculty

Back to Index
Alan Hiti, MD, PhD
Professor of Clinical Pathology
Director of Research Laboratory Services
Pathology
CT 1200 North State Street Health Sciences Campus Los Angeles
+1 323 442 3465

Publications

Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005 Nov; 84(6):363-76. View in: PubMed

Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood. 2004 Dec 01; 104(12):3445-53. View in: PubMed

Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood. 2004 Dec 1; 104(12):3445-53. View in: PubMed

Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells. Exp Hematol. 2004 May; 32(5):483-93. View in: PubMed

Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. Am J Hematol. 2002 Jul; 70(3):206-15. View in: PubMed

Comparative oncological studies of feline bronchioloalveolar lung carcinoma, its derived cell line and xenograft. Cancer Res. 2002 Jul 01; 62(13):3826-33. View in: PubMed

Comparative oncological studies of feline bronchioloalveolar lung carcinoma, its derived cell line and xenograft. Cancer Res. 2002 Jul 1; 62(13):3826-33. View in: PubMed

Ineffective erythropoiesis in beta-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage. Exp Hematol. 2000 Dec; 28(12):1343-53. View in: PubMed

Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood. 1999 Jan 1; 93(1):71-9. View in: PubMed

Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood. 1999 Jan 01; 93(1):71-9. View in: PubMed

An in vitro model of human erythropoiesis for the study of hemoglobinopathies. Ann N Y Acad Sci. 1998 Jun 30; 850:382-5. View in: PubMed

An in vitro model of human red blood cell production from hematopoietic progenitor cells. Blood. 1998 Apr 15; 91(8):2664-71. View in: PubMed

Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype. Oncogene. 1997 Oct 23; 15(17):2077-91. View in: PubMed

Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1997 Sep; 156(3 Pt 1):912-7. View in: PubMed

Beta-globin haplotypes from blood spots for follow-up of newborn hemoglobinopathy screening. Am J Hematol. 1997 Jan; 54(1):76-8. View in: PubMed

Multi-drug resistance to Streptococcus pneumoniae in sickle cell anemia. Am J Hematol. 1995 Apr; 48(4):278-9. View in: PubMed

Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):55-61. View in: PubMed

Sickle cell anemia. Beta s gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child. 1993 Nov; 147(11):1197-202. View in: PubMed

Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience. Am J Hematol. 1992 Mar; 39(3):176-82. View in: PubMed

Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991 Oct 15; 115(8):614-20. View in: PubMed

Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res. 1991 Jun 11; 19(11):3154. View in: PubMed

Plasminogen activator regulation by transforming growth factor-beta in normal and neoplastic human urothelium. Cancer Commun. 1990; 2(3):123-8. View in: PubMed

Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res. 1990 Jan 1; 50(1):44-7. View in: PubMed

Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res. 1990 Jan 01; 50(1):44-7. View in: PubMed

Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol Cell Biol. 1989 Nov; 9(11):4722-30. View in: PubMed

Powered bySC CTSI